Abstract P4-09-04: Associations between clinical factors in v7.02 of the Tyrer-Cuzick model and a SNP-based residual risk score von Hughes, ER, Rosenthal, E, Morris, B, Wagner, S, Lanchbury, JS, Gutin, A

Volltext

Abstract PD1-08: Development and validation of a combined residual risk score to predict breast cancer risk in unaffected women negative for mutations on a multi-gene hereditary ca... von Hughes, E, Judkins, T, Wagner, S, Rosenthal, E, Wenstrup, R, Lanchbury, JS, Gutin, A

Volltext

Single nucleotide polymorphisms and the future of genetic epidemiology von Schork, Nicholas J, Fallin, Daniele, Lanchbury, Jerry S

Volltext

Abstract P5-10-02: Development and validation of a polygenic score to predict breast cancer risk in unaffected Hispanic women negative for mutations on a multi-gene hereditary canc... von Hughes, ER, Wagner, S, Pruss, D, Gallagher, SK, Swedlund, B, Bulka, K, Hoff, R, Jammulapati, S, Morris, B, Perry, T, Lanchbury, JS, Gutin, A

Volltext

Genetic polymorphism of IL-12 p40 gene in immune-mediated disease von Hall, M A, McGlinn, E, Coakley, G, Fisher, S A, Boki, K, Middleton, D, Kaklamani, E, Moutsopoulos, H, Loughran, Jr, T P, Ollier, W E, Panayi, G S, Lanchbury, J S

Volltext

Abstract P1-06-07: Characterization of chromosomal instability in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or... von Sipos, O, Tovey, H, Quist, J, Haider, S, Nowinski, S, Gazinska, P, Kernaghan, S, Toms, C, Timms, KM, Lanchbury, JS, Linn, SC, Pinder, SE, Bliss, JM, Tutt, A, Cheang, MC, Grigoriadis, A

Volltext

Biomarker assessment of HR deficiency, tumor BRCA1/2 mutations and CCNE1 copy number in ovarian cancer: associations with clinical outcome following platinum monotherapy von Stronach, EA, Paul, J, Timms, KM, Hughes, E, Brown, K, Neff, C, Perry, M, Gutin, A, El-Bahrawy, M, Steel, JH, Liu, X, Lewsley, L-A, Siddiqui, N, Gabra, H, Lanchbury, JS, Brown, R

Volltext

Abstract P1-09-06: Prognostic and predictive relevance of cell cycle progression (CCP) score in ductal carcinoma in situ : Results from the UK/ANZ DCIS trial von Thorat, MA, Wagner, S, Jones, LJ, Levey, PM, Bulka, K, Hoff, R, Sangale, Z, Flake, DD, Bundred, NJ, Fentiman, IS, Forbes, JF, Lanchbury, JS, Cuzick, J

Volltext

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial von Tutt, A, Tovey, H, Cheang, MCU, Kernaghan, S, Kilburn, L, Gazinska, P, Owen, J, Abraham, J, Barrett, S, Barrett-Lee, P, Brown, R, Chan, S, Dowsett, M, Flanagan, JM, Fox, L, Grigoriadis, A, Gutin, A, Harper-Wynne, C, Hatton, MQ, Hoadley, KA, Parikh, J, Parker, P, Perou, CM, Roylance, R, Shah, V, Shaw, A, Smith, IE, Timms, KM, Wardley, AM, Wilson, G, Gillett, C, Lanchbury, JS, Ashworth, A, Rahman, N, Harries, M, Ellis, P, Pinder, SE, Bliss, JM

Volltext

The Human Endoplasmic Reticulum Molecular Chaperone BiP Is an Autoantigen for Rheumatoid Arthritis and Prevents the Induction of Experimental Arthritis von Corrigall, Valerie M, Bodman-Smith, Mark D, Fife, Mark S, Canas, Benito, Myers, Linda K, Wooley, Paul H, Soh, Cecilia, Staines, Norman A, Pappin, Darryl J. C, Berlo, Suzanne E, van Eden, Willem, van der Zee, Ruurd, Lanchbury, Jerry S, Panayi, Gabriel S

Volltext

Abstract P3-07-02: Prognostic and predictive relevance of HER2 status in ductal carcinoma in situ : Results from the UK/ANZ DCIS trial von Thorat, MA, Wagner, S, Jones, LJ, Levey, PM, Bulka, K, Hoff, R, Sangale, Z, Flake II, DD, Bundred, NJ, Fentiman, IS, Forbes, JF, Lanchbury, JS, Cuzick, J

Volltext

Abstract P6-05-10: Association between BRCA1/2 status and DNA-based assays for homologous recombination deficiency in breast cancer von Timms, KM, Abkevich, V, Neff, C, Morris, B, Potter, J, Tran, TV, Chen, J, Sangale, Z, Tikishvili, E, Zharkikh, A, Perry, M, Gutin, A, Lanchbury, JS

Volltext

Meta-analysis of genome searches von WISE, L. H., LANCHBURY, J. S., LEWIS, C. M.

Volltext

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer von Cuzick, J, Yang, ZH, Fisher, G, Tikishvili, E, Stone, S, Lanchbury, JS, Camacho, N, Merson, S, Brewer, D, Cooper, CS, Clark, J, Berney, DM, Møller, H, Scardino, P, Sangale, Z, Transatlantic Prostate Group

Volltext

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort von Cuzick, J, Berney, DM, Fisher, G, Mesher, D, Møller, H, Reid, JE, Perry, M, Park, J, Younus, A, Gutin, A, Foster, CS, Scardino, P, Lanchbury, JS, Stone, S, Transatlantic Prostate Group

Volltext

Strategy for Controlling Preferential Amplification and Avoiding False Negatives in PCR Typing von Weissensteiner, Thomas, Lanchbury, Jerry S

Volltext

Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine von Keen, R.W, Woodford-Richens, K.L, Lanchbury, J.S, Spector, T.D

Volltext

Quantitative-Trait Loci on Chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 Control Variation in Levels of T and B Lymphocyte Subpopulations von Hall, M.A., Norman, P.J., Thiel, B., Tiwari, H., Peiffer, A., Vaughan, R.W., Prescott, S., Leppert, M., Schork, N.J., Lanchbury, J.S.

Volltext

Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-depend... von Thornhill, MH, Wellicome, SM, Mahiouz, DL, Lanchbury, JS, Kyan-Aung, U, Haskard, DO

Volltext

Evolution of Major Histocompatibility Complex Polymorphisms and T-Cell Receptor Diversity in Primates von BONTROP, RONALD E., OTTING, NEL, SLIERENDREGT, BAS L., LANCHBURY, JERRY S.

Volltext